|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin 显示文摘 | NANGIA-MAKKER P HOGAN V HONJO Y | 2002 | J Natl Cancer Inst2002，94，24： | 1 |
| 2 | Synthesis properties and catalytic behaviour of zeolite Nu-10 显示文摘 | HOGAN P J WHITTAM T V BIRTILL J | 1984 | Zeolites1984，4，3： | 1 |
| 3 | Purification of B16 F1 melanoma autocrine motility factor and its receptor显示文摘 | Silletti S Watanabe H Hogan V | 1991 | Cancer Res1991，51，13： | 1 |
| 4 | Galectin-3 in apoptosis, a novel therapeutic target 显示文摘 | Nangia-Makker P Nakahara S Hogan V | 2007 | J Bioenerg Biomembr2007，39，： | 1 |
| 5 | Patient safety surveyreport 显示文摘 | Manno M Hogan P Heberlein V | 2006 | Nursing2006，36，5： | 1 |
| 6 | Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin显示文摘 | KJ Pienta H Naik A Akhtar K Yamazaki TS Replogle J Lehr TL Donat L Tait V Hogan and A Raz | 1995 | J Natl Cancer Inst1995，，87： | 1 |
| 7 | Phosphoglucose isomerase/au- tocrine motility factor mediates epithelial and mesenchymal phe- notype conversions in breast cancer显示文摘 | Funasaka T Hogan V Raz A | 2009 | Cancer research2009，69，13： | 1 |
| 8 | Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin显示文摘 | Nangia-Makker P Hogan V Honjo Y Baccarini S Tait L Bresalier R Raz A | | 0，，24： | 1 |
| 9 | Carbohydrate-binding proteins in cancer,and their ligands as therapeutic agents显示文摘 | Nangia-Makker P Conklin J Hogan V Raz A | | 0，，04： | 1 |
| 10 | Galectin 3 in apoptosis, a novel therapeutic target 显示文摘 | NANGIA-MAKKER P NAKAHARA S HOGAN V | 2007 | J Bioenerg Biomembr2007，39，1： | 1 |
| 11 | Stroke-specific FIM Models in an Urban Population显示文摘 | Cavanagh S J Hogan K Gordon V | 2000 | J Neurosci Nurs2000，32，1： | 1 |
| 12 | Genetically modified plants and food hypersensitivity diseases: usage and implications of experimental models for risk assessment 显示文摘 | PRESCOTT V E HOGAN S P | 2006 | Pharmacol Ther2006，111，2： | 1 |
| 13 | Efficacy of an Escherichia coli J5 Bacterin Administered to Primigraved Heifers 显示文摘 | Hogan J S Bogacz V L Aslam M | 1999 | J Dairy Sci1999，82，5： | 1 |
| 14 | Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin显示文摘 | Nangia-Makker P Hogan V Honjo Y | 2002 | Journal of The National Cancer Institute2002，94，24： | 1 |
| 15 | The joint effect of vaginal Ureaplasma urealyticum and bacterial vaginosis on adverse pregnancy outcomes显示文摘 | Thorsen P Hogan V K | 2006 | Acta Obstet Gynecol Scand2006，85，： | 1 |
| 16 | Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin 显示文摘 | Nangia-Makker P Hogan V Honjo Y | 2002 | J Natl Cancer Inst2002，94，24： | 1 |
| 17 | Localization of the mouse gene for secreted phosphoprotein 1 (Spp-1) (2ar, osteopontin, bone sialoprotein 1,44-kDa bone phosphoprotein, tumor-secreted phos- phoprotein) to chromosome 5, closely linked to Ric ( Rickettsia re- sistance) 显示文摘 | FET V DICKINSON M E HOGAN B L | 1989 | Genomics1989，5，2： | 1 |
| 18 | Galectin-3 in apoptosis, a novel therapeutic target 显示文摘 | Nangia-Makker P Nakahara S Hogan V | 2007 | J Bioenerg Biomembr2007，39，1： | 1 |
| 19 | Organizational culture, innova- tion, and performance: A test of Schein model 显示文摘 | Hogan S J Coote L V | 2014 | Journal of Business Research2014，67，8： | 1 |
| 20 | Carbohydrate-binding proteins in cancer, and their ligands therapeutic agents 显示文摘 | Nangia M P Conklin J Hogan V | 2002 | Trends Mol Med2002，8，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员